Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Publisher: John Wiley & Sons Inc

E-ISSN: 2047-9980|5|4|JAHA.115.002850-JAHA.115.002850

ISSN: 2047-9980

Source: JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.5, Iss.4, 2016-04, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content